Trial Demonstrates Safety and Efficacy of HIV Combination Therapy – Drug for nerve pain boosts high for opioid abusers.

2507_GraphicImage_062315-piAabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Trial Demonstrates Safety and Efficacy of HIV Combination Therapy – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

Data from a recent clinical trial show that a high proportion of patients with human immunodeficiency virus (HIV) achieved an undetectable viral load through 48 weeks after rapidly starting Janssen’s single-tablet antiretroviral therapy (ART) containing darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide 10 mg D/C/F/TAF.

The 4-drug combination tablet (Symtuza) was approved by the FDA in July 2018 for infection of HIV type 1 (HIV-1) in treatment-naïve and certain virologically suppressed adults.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.